Product List

Description of Lapanix

Lapatinib, a 4-anilinoquinazoline, is an inhibitor of the intracellular tyrosine kinase domains of both EGFR (ErbB1) and of HER2 (ErbB2) receptors. Lapatinib retained significant activity against HER2-amplified breast cancer cell lines selected for long-term growth in trastuzumab-containing medium in vitro and was synergistic in combination with trastuzumab in these cell lines.

Generic Brand Name Formulation & Strength Pack Size
Lapatinib Lapanix Tablet ( 250 mg ) 150's Pot

Website Prescribing Information Order Now